Ginkgo Bioworks Holdings, Inc.

BMV:DNA * Stock Report

Market Cap: Mex$9.4b

Ginkgo Bioworks Holdings Management

Management criteria checks 3/4

Ginkgo Bioworks Holdings' CEO is Jason Kelly, appointed in Jan 2008, has a tenure of 16.83 years. total yearly compensation is $262.50K, comprised of 95.2% salary and 4.8% bonuses, including company stock and options. directly owns 4.03% of the company’s shares, worth MX$378.89M. The average tenure of the management team and the board of directors is 6.3 years and 1.5 years respectively.

Key information

Jason Kelly

Chief executive officer

US$262.5k

Total compensation

CEO salary percentage95.2%
CEO tenure16.8yrs
CEO ownership4.0%
Management average tenure6.3yrs
Board average tenure1.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jason Kelly's remuneration changed compared to Ginkgo Bioworks Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$651m

Jun 30 2024n/an/a

-US$898m

Mar 31 2024n/an/a

-US$854m

Dec 31 2023US$263kUS$250k

-US$893m

Sep 30 2023n/an/a

-US$857m

Jun 30 2023n/an/a

-US$1b

Mar 31 2023n/an/a

-US$2b

Dec 31 2022US$263kUS$250k

-US$2b

Sep 30 2022n/an/a

-US$4b

Jun 30 2022n/an/a

-US$3b

Mar 31 2022n/an/a

-US$2b

Dec 31 2021US$381mUS$250k

-US$2b

Sep 30 2021n/an/a

-US$276m

Jun 30 2021n/an/a

-US$200m

Mar 31 2021n/an/a

-US$175m

Dec 31 2020US$11mUS$250k

-US$127m

Compensation vs Market: Jason's total compensation ($USD262.50K) is about average for companies of similar size in the MX market ($USD244.75K).

Compensation vs Earnings: Jason's compensation has been consistent with company performance over the past year.

CEO

Jason Kelly (43 yo)

16.8yrs

Tenure

US$262,500

Compensation

Dr. Jason Kelly serves as Director of Genomatica, Inc. Dr. Kelly founded Ginkgo Bioworks, Inc. (nka:Ginkgo Bioworks Holdings, Inc.) in 2008 and serves as its Chief Executive Officer and has been Director s...

Leadership Team

NamePositionTenureCompensationOwnership
Jason Kelly
Founder16.8yrsUS$262.50k4.03%
MX$ 378.9m
Reshma Shetty
Founder16.8yrsUS$262.50k4.39%
MX$ 412.5m
Mark Dmytruk
Chief Financial Officer4yrsUS$1.69m0.089%
MX$ 8.3m
Thomas Knight
Founderno datano datano data
Austin Che
Founderno datano data4.5%
MX$ 422.8m
Bartholomew Canton
Founderno datano data4.38%
MX$ 411.6m
Steven Coen
Chief Accounting Officer1.5yrsno data0.012%
MX$ 1.1m
Karen Tepichin
General Counsel & Secretaryno datano datano data
Anna Wagner
Senior Vice President of Corporate Developmentno datano datano data
Samantha Sutton
Head of People6.8yrsno datano data
Joshua Dunn
Head of Design6.1yrsno datano data
Joaquim Marques
Head of Omics & Analytical Chemistry6.3yrsno datano data

6.3yrs

Average Tenure

43yo

Average Age

Experienced Management: DNA *'s management team is seasoned and experienced (6.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jason Kelly
Founder16.8yrsUS$262.50k4.03%
MX$ 378.9m
Reshma Shetty
Founder16.8yrsUS$262.50k4.39%
MX$ 412.5m
Norbert Bischofberger
Member of Biopharma Advisory Boardless than a yearno datano data
John M. Maraganore
Member of Biopharma Advisory Boardless than a yearno datano data
Harry Sloan
Independent Director3.2yrsUS$459.38k1.56%
MX$ 146.7m
Mark McCamish
Member of Biopharma Advisory Boardless than a yearno datano data
Christian O. Henry
Independent Director8.8yrsUS$477.50k0.063%
MX$ 5.9m
Kathy Hannan
Independent Director2.3yrsUS$448.67k0.0079%
MX$ 741.0k
Christi Shaw
Member of Biopharma Advisory Boardless than a yearno datano data
Shyam Sankar
Independent Chairman of the Board9.8yrsUS$485.19k0.12%
MX$ 10.9m
Jeff Legos
Member of Biopharma Advisory Boardless than a yearno datano data
Paolo Martini
Member of Biopharma Advisory Boardless than a yearno datano data

1.5yrs

Average Tenure

59.5yo

Average Age

Experienced Board: DNA *'s board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.